LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 10 of 497
Next
>>
>
226 to 250 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PD0325901	0.04	uM	LJP5	1	C06	72	hr	1097	2749	3769	0.7293	0.6181
BT-20	PD0325901	0.04	uM	LJP5	2	C06	72	hr	1097	2862	3769	0.7592	0.6604
BT-20	PD0325901	0.04	uM	LJP5	3	C06	72	hr	1097	3301	3769	0.8757	0.8247
BT-20	PD0325901	0.04	uM	LJP6	1	E06	72	hr	1097	3509	3769	0.9309	0.9025
BT-20	PD0325901	0.04	uM	LJP6	2	E06	72	hr	1097	3058	3769	0.8112	0.7337
BT-20	PD0325901	0.04	uM	LJP6	3	E06	72	hr	1097	3413	3769	0.9054	0.8666
BT-20	PD173074	0.04	uM	LJP6	1	I12	72	hr	1097	3973	3769	1.0540	1.0761
BT-20	PD173074	0.04	uM	LJP6	2	I12	72	hr	1097	3785	3769	1.0041	1.0058
BT-20	PD173074	0.04	uM	LJP6	3	I12	72	hr	1097	4067	3769	1.0789	1.1113
BT-20	PD184352	0.04	uM	LJP5	1	L12	72	hr	1097	3875	3769	1.0280	1.0395
BT-20	PD184352	0.04	uM	LJP5	2	L12	72	hr	1097	4177	3769	1.1081	1.1525
BT-20	PD184352	0.04	uM	LJP5	3	L12	72	hr	1097	4333	3769	1.1495	1.2109
BT-20	Pelitinib	0.04	uM	LJP5	1	I18	72	hr	1097	3281	3769	0.8704	0.8172
BT-20	Pelitinib	0.04	uM	LJP5	2	I18	72	hr	1097	3582	3769	0.9503	0.9298
BT-20	Pelitinib	0.04	uM	LJP5	3	I18	72	hr	1097	3581	3769	0.9500	0.9295
BT-20	PF431396	0.04	uM	LJP5	1	E12	72	hr	1097	3809	3769	1.0105	1.0148
BT-20	PF431396	0.04	uM	LJP5	2	E12	72	hr	1097	3586	3769	0.9513	0.9313
BT-20	PF431396	0.04	uM	LJP5	3	E12	72	hr	1097	3510	3769	0.9312	0.9029
BT-20	PF477736	0.04	uM	LJP5	1	J24	72	hr	1097	3500	3769	0.9285	0.8991
BT-20	PF477736	0.04	uM	LJP5	2	J24	72	hr	1097	3451	3769	0.9155	0.8808
BT-20	PF477736	0.04	uM	LJP5	3	J24	72	hr	1097	3736	3769	0.9911	0.9875
BT-20	PF562271	0.04	uM	LJP6	1	F18	72	hr	1097	3248	3769	0.8616	0.8048
BT-20	PF562271	0.04	uM	LJP6	2	F18	72	hr	1097	3782	3769	1.0033	1.0047
BT-20	PF562271	0.04	uM	LJP6	3	F18	72	hr	1097	3188	3769	0.8457	0.7824
BT-20	PHA-665752	0.04	uM	LJP5	1	F18	72	hr	1097	3929	3769	1.0423	1.0597

|<
<<
Previous
Page 10 of 497
Next
>>
>
226 to 250 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)